benefits of retatrutide peptide Explained: Benefits, Mechanism & Clinical Insights First Retatrutide phase 3 data,

Unless specifically prescribed, most patients will be on a once-weekly injection schedule with medications like semaglutide or tirzepatide

This coincides with results from previous meta-analyses in which GLP-1 agonists were associated with a 15% lower risk of nonfatal stroke and a 16% lower risk of total stroke [26,27]

GLP-1 medications help keep glucose levels more stable throughout the day, preventing sharp spikes after meals and improving long-term diabetes management

DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes

Semaglutide GLP-1 is known as a GLP-1 receptor agonist

J., Aylor, K